Respiratory Syncytial Virus (RSV) Vaccine

Respiratory Syncytial Virus (RSV) vaccine helps protect the body against RSV, a virus that can cause bronchiolitis and pneumonia. It also elevates the risk of cardiovascular events such as myocardial infarction, heart failure and stroke, which can be fatal.

RSV is particularly dangerous for infants, the elderly, and individuals with underlying medical conditions such as chronical lung disease, coronary artery disease, heart failure, diabetes, or immunodeficiency.

Recommended For
  • Adults aged 60 and older
  • Pregnant women from the 24th to the 36th week of pregnancy

Preventive Medicine Centre

MessengerZalo